Discovery of novel N2-indazole derivatives as phosphodiesterase 4 inhibitors for the treatment of inflammatory bowel disease
Lei Zheng(Southern Medical University), Zhong‐Zhen Zhou(Guangdong Pharmaceutical University), Jiaxi Huang(Guangdong Pharmaceutical University), Chuang Xia(Guangdong Special Equipment Inspection and Research Institute), Kun Chen(Second Affiliated Hospital of Zhejiang University), Jigang Wang(Qingdao University), Yifan Xie(Guangdong Pharmaceutical University), Yifan Bao(Guangdong Baiyun University), Huichang Bi(Southern Medical University)
Cited by 8
Related Papers
Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum
|Nature Communications|2015|640
Current trends in drug metabolism and pharmacokinetics
|Acta Pharmaceutica Sinica B|2019|391
SIRT6 as a key event linking P53 and NRF2 counteracts APAP-induced hepatotoxicity through inhibiting oxidative stress and promoting hepatocyte proliferation
|Acta Pharmaceutica Sinica B|2020|129
Optimization of harvesting, extraction, and analytical protocols for UPLC-ESI-MS-based metabolomic analysis of adherent mammalian cancer cells
|Analytical and Bioanalytical Chemistry|2013|126